Michael Schröter
Gestionnaire de Portefeuille-Actions chez HSBC Global Asset Management (Switzerland) AG
Profil
Michael Schröter founded Apotech SA in 1996 and Zoeyplus AG in 2018, where he worked as Founding Partner from 2018 to 2023.
Dr. Schröter also currently works at HSBC Global Asset Management (Switzerland) AG, as Co-Head Sustainable Healthcare Equity from 2021.
Dr. Schröter also formerly worked at BioMers Pte Ltd., as Director, Eli Lilly & Co., as Principal from 2000 to 2002, RF Nano Corp., as Vice President-Engineering, Roche AB, as Head Personalised Reimbursement Models from 2014 to 2018, Roche Singapore Pte Ltd., as Head Singapore Translational Medicine Hub from 2010 to 2012, and Eli Lilly (Singapore) Pte Ltd., as COO from 2007 to 2010.
Dr. Schröter received his graduate degree from the University of Basel, doctorate degree from the University of Lausanne, and Masters Business Admin degree from International Institute for Management Development.
Postes actifs de Michael Schröter
| Sociétés | Poste | Début |
|---|---|---|
HSBC Global Asset Management (Switzerland) AG
 HSBC Global Asset Management (Switzerland) AG Investment ManagersFinance Part of HSBC Holdings Plc, HSBC Global Asset Management (Switzerland) AG provides investment advice. The company is based in Zurich, Switzerland. Isabelle Brancart has been the CEO of the Swiss company since 2019. | Gestionnaire de Portefeuille-Actions | 01/01/2021 |
Anciens postes connus de Michael Schröter
| Sociétés | Poste | Fin |
|---|---|---|
Viopas Partners AG
 Viopas Partners AG Investment ManagersFinance Zoeyplus AG(Zoeyplus) is a Private Equity subsidiary of Viopas Venture Consulting GmbH founded in 2018 by Simon Jules Nebel, Nathalie Flury and Michael Schröter. The firm is headquartered in Zurich, Switzerland. | Fondateur | 10/01/2023 |
Roche AB
 Roche AB Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare. | Corporate Officer/Principal | 30/10/2018 |
| Roche Singapore Pte Ltd. | Corporate Officer/Principal | 01/01/2012 |
Eli Lilly (Singapore) Pte Ltd.
 Eli Lilly (Singapore) Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly (Singapore) Pte Ltd. is a Singaporean pharmaceutical company that manufactures pharmaceutical products. The company is based in Singapore, Singapore. | Directeur/Membre du Conseil | 01/01/2010 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2002 |
Formation de Michael Schröter
| University of Basel | Graduate Degree |
| University of Lausanne | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 8 |
|---|---|
RF Nano Corp.
 RF Nano Corp. Electronic Production EquipmentElectronic Technology RF Nano Corp. developed a CMOS compatible suite of discrete, wafer and integrated circuit products. Its robust carbon nanotube devices revolutionized radio frequency, analog and mixed signal electronics. The firm's technology was used in microprocessors, microcontrollers, static RAM and other digital logic circuits. The company was founded by Peter John Burke and Steffen McKernan in 2005 and was headquartered in Newport Beach, CA. | Electronic Technology |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare. | Health Technology |
| Roche Singapore Pte Ltd. | |
BioMers Pte Ltd.
 BioMers Pte Ltd. Medical SpecialtiesHealth Technology BioMers Pte Ltd. provides medical devices. It specializes in the development of novel polymer composite technology for biomedical applications. The firm offers orthodontics the total aesthetic solution: wires, brackets and retainers. The company was founded by George Aliphtiras and Mervin Fathianathan in 2005 and is headquartered in Midview City, Singapore. | Health Technology |
| Apotech SA | |
HSBC Global Asset Management (Switzerland) AG
HSBC Global Asset Management (Switzerland) AG Investment ManagersFinance Part of HSBC Holdings Plc, HSBC Global Asset Management (Switzerland) AG provides investment advice. The company is based in Zurich, Switzerland. Isabelle Brancart has been the CEO of the Swiss company since 2019. | Finance |
Eli Lilly (Singapore) Pte Ltd.
Eli Lilly (Singapore) Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly (Singapore) Pte Ltd. is a Singaporean pharmaceutical company that manufactures pharmaceutical products. The company is based in Singapore, Singapore. | Health Technology |
Viopas Partners AG
Viopas Partners AG Investment ManagersFinance Zoeyplus AG(Zoeyplus) is a Private Equity subsidiary of Viopas Venture Consulting GmbH founded in 2018 by Simon Jules Nebel, Nathalie Flury and Michael Schröter. The firm is headquartered in Zurich, Switzerland. | Finance |
